Упрощенная HTML-версия
125
156.
Risau W. Mechanisms of angiogenesis / W. Risau // Nature. – 1987.
– V.386. – P.671-674.
157.
Roman M.E. Parallel cardiac and vascular adaptation in hypertension
/ M.E. Roman, P.S. Saba, R. Rini et al. // Circulation. – 1992. – V.86. – P.1909-
1918.
158.
Sadler J.E. Von Willebrand factor / J.E. Sadler // J Biol Chem. –
1991. – V. 266. – P. 22777–22784.
159.
Sander M. Sympathetically mediated hypertension caused by chronic
inhibition of nitric oxide / M. Sander, P.G. Hansen, R.G. Victor // Hypertension.
– 1995. – V.26. – P. 691-695.
160.
Scherrer U. Nitric oxide release accounts for insulin’s vascular ef-
fects in humans / U. Scherrer, D. Randin, P. Vollenweider et al. // J. Clin. Invest.
– 1994. – V. 94. – P.2511–2515.
161.
Spencer C.G.C. Haemoreological factors in hypertension / C.G.C.
Spencer, G.Y.N. Lip // J Human Hypertens. – 2000. – V.14. – P. 291-293.
162.
Spieker L.E. Working under pressure: the vascular endothelium in
arterial hypertension / L.E. Spieker, G. Noll, F.T. Ruschitzka et al. // Journal of
Human Hypertesion. –2000. – V.14. – P.617-630.
163.
Stadler R.W. Measurement of the time course of peripheral vasoac-
tivity: results of cigarette smokers / R.W. Stadler, S.F. Ibrahim, R.S. Lees // Ath-
erosclerosis. – 1998. – V. 138. – P. 197-206.
164.
Steinberg H.O. Insulin-mediated skeletal muscle vasodilation is ni-
tric oxide dependent / H.O. Steinberg, G. Brechtel, A. Johnson et al. // J. Clin.
Invest. – 1994. – V. 94. – P.1172–1179.
165.
Steinberg H.O. Obesity/Insulin Resistance Is Associated with
Endothelial Dysfunction / H.O. Steinberg, H. Chaker, R. Leaming et al. // J.
Clin. Invest. – 1996. – V.97. – P.2601-2610.
166.
Stern M.P. Diabetes and cardiovascular disease the common soil hy-
pothesis / M.P. Stern // Diabetes. – 1995. – V. 44. – P. 369-374.